Ferrin Williams, PharmD MBA’s Post

View profile for Ferrin Williams, PharmD MBA, graphic

Pharmacist on a mission to make prescription drugs affordable

🚨 Big News in Biopharma! 🚨 The FTC is backing the FDA’s proposal to streamline biosimilar interchangeability! 📈💊 This new draft guidance could make it easier for biosimilars to gain interchangeability designations by using existing data instead of conducting new clinical studies. 🏷️🧪 This change would allow pharmacists to substitute biosimilars for brand-name biologics without additional prescriber approval, boosting competition and patient access. 🏥✅ With 56 biosimilars approved but only 13 interchangeable so far, this could greatly increase the number of interchangeable options. 📊🔬 Scripta Insights is ready to help patients navigate through these exciting changes! 🌐✨ #Biosimilars #FDA #FTC #HealthcareInnovation #PatientAccess #Biopharma #DrugPricing Scripta Insights

FTC endorses FDA's plan to simplify biosimilar interchangeability

FTC endorses FDA's plan to simplify biosimilar interchangeability

ml.firstwordpharma.com

To view or add a comment, sign in

Explore topics